Inna Thalmann

Inna is Co-Founder and COO of Neurolytic Healthcare Inc (dba Mable). Prior to this, Inna completed her PhD in Health Economics, where she used large healthcare datasets to investigate treatment gaps in chronic disease management. She has consulting expertise in market access, reimbursement and regulatory approval strategy for medical devices.